This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
TGFB2 · Western blot design guide
Design a Western Blot for TGFB2
Real validated TGFB2 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-TGFB2 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Last reviewed: May 2026 · Scientific review: Boster Bio technical team
TGFB2 Western Blot Experimental Design Guide
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
Must know before running
| Expected band | ~47.7 kDa | |
| Observed band | ~48 kDa | |
| Gel | 10–12% | |
| Negative control | siRNA / KO lysate |
Important caveats
Reasons your observed band may differ from the expected size.
| PTM | Glycosylated + Cleaved | |
| Caveat | N-linked glycosylation | |
| Regulation | Apoptosis | |
| Isoform | 2 isoform(s) |
Section 1
Real Curated TGFB2 Western Blot Protocols
Literature-validated Western blot parameters for TGFB2 — gel percentage, transfer, blocking, antibody incubation and detection, extracted from published methods.
| Sample / lysate | human HCCT , Lane 2: huamn HCCP . After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-TGF beta 2 antigen affinity purified polyclonal antibody (Catalog # A00892-1) at 0.5 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for TGF beta 2 at approximately 48 kDa. The expected band size for TGF beta 2 is at 48 kDa |
| Gel % | 10–12% |
| Load | 30 ug |
| Transfer | nitrocellulose membrane, 150 mA, 50–90 min |
| Membrane | nitrocellulose |
| Blocking | 5% non-fat milk / TBS, 1.5 h RT |
| Primary antibody | 0.5 µg/mL |
| Primary incubation | overnight at 4 °C |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:5000 |
| Wash | TBS-0.1% Tween, 3 × 5 min |
| Detection | ECL |
| Exposure / imaging | Tanon 5200 |
| Observed band | 48 kDa |
Section 2
What Is the Expected TGFB2 Western Blot Band Size?
TGFB2's 47.7 kDa predicted proprotein closely matches its ~48 kDa observed band, with N-glycosylation and disulfide-linked dimerization driving any upward size variation.
| Single band near 48 kDa | matches the predicted 47.7 kDa TGFB2 proprotein, consistent with the empirically observed ~48 kDa band |
| Band running slightly above the 47.7 kDa baseline or appearing slightly diffuse | reflects added carbohydrate mass and heterogeneity from N-glycosylation at Asn72, Asn140, and Asn241 |
| Additional band at roughly double the monomer mass (~96 kDa) under non-reducing or partially reducing conditions | corresponds to the covalent homodimer formed through the interchain disulfide bond at Cys379 |
| Faint or absent band in whole-cell lysate | TGFB2 is secreted into the extracellular space and matrix, so little full-length protein remains intracellularly to detect in lysate |
| Two or more distinct bands at different apparent masses | arises from alternative splicing, since isoforms A and B differ in sequence content |
💡Expected TGFB2 appearanceExpect the dominant TGFB2 band at ~48 kDa, consistent with the 47.7 kDa proprotein and the antibody's observed band, with a minor upward smear from N-glycosylation and a possible ~96 kDa disulfide-linked homodimer band.
| Predicted proprotein mass (47.7 kDa, 414 aa) | sets the baseline unmodified band size, closely matching the ~48 kDa band typically observed |
| N-glycosylation at Asn72, Asn140, and Asn241 | adds carbohydrate mass and heterogeneity, shifting or smearing the band slightly above the 47.7 kDa baseline |
| Interchain disulfide bond at Cys379 / homodimer formation | produces a band at roughly double the monomer mass (~96 kDa) when reduction is incomplete |
| Alternative splicing isoforms A and B | can yield an additional band at a different apparent mass, since isoform B differs in sequence content from canonical isoform A |
| Signal peptide cleavage (residues 1-20) | removes a small N-terminal segment from the translated precursor, so the processed species runs slightly below the unprocessed translation product |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | TGFB2 is secreted into the extracellular space and matrix, so whole-cell lysates may retain little of the protein | test conditioned media, ECM-enriched extracts, or tissue lysates with known TGFB2 expression rather than relying solely on cell pellets |
| Band higher than expected | incomplete reduction leaves the Cys379 interchain disulfide bond intact, preserving the covalent homodimer | use fresh reducing agent, increase DTT or beta-mercaptoethanol concentration, and boil the sample fully before loading |
| Broad smear instead of sharp band | heterogeneous occupancy and processing of the three N-glycosylation sites generates a mixture of glycoforms | treat lysate with PNGase F to remove N-glycans and confirm collapse to a single sharper band |
| Multiple bands | alternative splicing produces isoforms A and B with different sequence content and apparent mass | check which isoform the antibody epitope maps to and compare band pattern against the datasheet's expected isoform reactivity |
| Band lower than expected | removal of the signal peptide or other proteolytic processing trims residues from the precursor | confirm the antibody epitope lies outside the processed region and verify against the antibody's stated immunogen |
Experiment evidence
Western blot images showing TGFB2 band
A00892-1 · TGFB2
← swipe / scroll for more images →
Real WB data behind the band-size expectations in this section.
Sample controls for TGFB2 Western blot
🧪For positive controls for TGFB2 in Western blot, you can use conditioned medium concentrated from a cell line known to secrete TGFB2, or recombinant TGFB2 protein, since no positive tissue data is available from the Human Protein Atlas for this protein.
Positive control: Conditioned medium / recombinant TGFB2 protein
Negative control: ubiquitously expressed; use siRNA knockdown or KO line
Loading controls: Run GAPDH and β-actin alongside a total-protein stain (stain-free gel, Ponceau S, or REVERT) as loading controls.
⚠️Feasibility: As a secreted protein with no HPA tissue data, TGFB2 gives weak signal in whole-cell lysate and lacks a clear negative tissue, so use conditioned medium and confirm specificity with siRNA/KO.
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
Positive expression · recommended positive controls
| Tissue | Cell type | Level | Evidence | Source |
|---|
Undetected expression · recommended negative controls
| Tissue | Cell type | Level | Evidence | Source |
|---|
Section 3
Advanced TGFB2 Western Blot Tips
Deeper troubleshooting and optimisation questions for TGFB2, answered from its protein features.
Why does TGFB2 run near its predicted 47.7 kDa mass?
The ~48 kDa band matches the full-length glycosylated proprotein rather than a processed fragment. No separate propeptide entry is annotated, but cleavage occurs at a paired basic residue site, so lysates can show the intact precursor near 48 kDa unless downstream processing to the mature growth factor has occurred.
Could TGFB2 isoforms A or B change the band pattern?
TGFB2 has two alternatively spliced isoforms, A and B. If an antibody's epitope falls in a region unique to one isoform, only a single band may appear even though both transcripts are expressed. Check the immunogen sequence against both isoform records before troubleshooting an apparently missing band.
Which blocking buffer reduces TGFB2 background signal?
Avoid milk-based blocking buffers, since milk naturally contains TGF-beta family growth factors that can bind antibodies non-specifically and raise background. A BSA-based blocking buffer is preferable for this secreted, glycosylated growth factor to achieve a cleaner signal at the expected band size.
What transfer method to use for TGFB2 Western blot?
Use wet transfer under fully reducing conditions to break the five disulfide bonds stabilizing TGFB2. Incomplete reduction can leave disulfide-linked oligomers that transfer poorly, producing faint or smeared signal instead of a clean band at the expected precursor mass.
How is secreted TGFB2 activated into its mature form?
TGFB2 is secreted as a latent complex with its latency-associated peptide anchored in the extracellular matrix. Proteolytic activation by serine proteases such as HTRA1 and HTRA3 releases the mature growth factor. Samples from unstimulated cells may therefore show mostly the latent precursor rather than an activated fragment.
Why avoid housekeeping proteins to normalize TGFB2 blots?
TGFB2 is a secreted extracellular matrix protein, not a constitutive cytosolic protein, so cytosolic housekeeping controls like actin do not track with its expression or secretion levels. Total protein stain normalization gives a more reliable loading reference for this growth factor.
What explains extra bands below 47.7 kDa on TGFB2 blots?
Cleavage at the paired basic residue site separates the latency-associated propeptide from the smaller mature growth factor monomer, and disulfide-linked dimers can appear at an intermediate size under non-reducing conditions. These lower bands typically reflect normal proprotein processing rather than degradation.
Does glycosylation shift TGFB2's apparent molecular weight?
TGFB2 carries three predicted glycosylation sites that add mass and heterogeneity beyond the 47.7 kDa calculated core sequence, which can cause slightly higher or diffuse migration on SDS-PAGE. Enzymatic deglycosylation can sharpen a smeared band if this heterogeneity obscures quantitation.
Boster reagents
Best TGFB2 Western Blot Antibodies
BosterBio's TGFB2 antibodies are among the best-performing WB antibodies on the market — well cited, thoroughly validated, and orthogonally cross-validated against negative tissues and complementary methods.
Real WB data
Anti-TGF beta 2/TGFB2 Antibody Picoband®
Cat # A00892-1
Our recommended anti-TGFB2 antibody is a best-performing, extensively cited reagent, thoroughly validated by Western blot and orthogonally cross-validated against negative tissue controls and complementary detection methods, ensuring specific, reproducible detection of TGF-beta 2 across experimental systems.
Which to pick: Only one Boster anti-TGFB2 antibody is catalogued, A00892-1, which includes a genuine Western blot validation image, making it the clear choice for reliable TGF-beta 2 detection in your experiments.
Source: BosterBio TGFB2 gene-info card — filtered to Western-blot-capable antibodies; each card shows that product's actual WB validation figure.
References
- UniProt Consortium. UniProt entry P61812.
- Human Protein Atlas. TGFB2 tissue expression.